Literature DB >> 16765894

Docking interactions induce exposure of activation loop in the MAP kinase ERK2.

Tianjun Zhou1, Liguang Sun, John Humphreys, Elizabeth J Goldsmith.   

Abstract

MAP kinases bind activating kinases, phosphatases, and substrates through docking interactions. Here, we report a 1.9 A crystallographic analysis of inactive ERK2 bound to a "D motif" docking peptide (pepHePTP) derived from hematopoietic tyrosine phosphatase, a negative regulator of ERK2. In this complex, the complete D motif interaction defined by mutagenic analysis is observed, including extensive electrostatic interactions with the "CD" site of the kinase. Large conformational changes occur in the activation loop where the dual phosphorylation sites, which are buried in the inactive form of ERK2, become exposed to solvent in the complex. Similar conformational changes occur in a complex between ERK2 and a MEK2 (MAP/ERK kinase-2)-derived D motif peptide (pepMEK2). D motif peptides are known to bind homologous loci in the MAP kinases p38alpha and JNK1, also inducing conformational changes in these enzymes. However, the binding interactions and conformational changes are unique to each, thus contributing to specificity among MAP kinases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765894     DOI: 10.1016/j.str.2006.04.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  80 in total

1.  ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4.

Authors:  Myoung Ok Kim; Sung-Hyun Kim; Yong-Yeon Cho; Janos Nadas; Chul-Ho Jeong; Ke Yao; Dong Joon Kim; Dong-Hoon Yu; Young-Sam Keum; Kun-Yeong Lee; Zunnan Huang; Ann M Bode; Zigang Dong
Journal:  Nat Struct Mol Biol       Date:  2012-02-05       Impact factor: 15.369

2.  Examining docking interactions on ERK2 with modular peptide substrates.

Authors:  Sunbae Lee; Mangalika Warthaka; Chunli Yan; Tamer S Kaoud; Pengyu Ren; Kevin N Dalby
Journal:  Biochemistry       Date:  2011-10-18       Impact factor: 3.162

3.  The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module.

Authors:  Natarajan Kannan; Nina Haste; Susan S Taylor; Andrew F Neuwald
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

Review 4.  Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.

Authors:  Michael J Schnieders; Tamer S Kaoud; Chunli Yan; Kevin N Dalby; Pengyu Ren
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.

Authors:  Kimberly A Burkhard; Fengming Chen; Paul Shapiro
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

6.  Docking interactions of hematopoietic tyrosine phosphatase with MAP kinases ERK2 and p38α.

Authors:  Andrea Piserchio; Dana M Francis; Dorothy Koveal; Kevin N Dalby; Rebecca Page; Wolfgang Peti; Ranajeet Ghose
Journal:  Biochemistry       Date:  2012-10-05       Impact factor: 3.162

7.  Crystal structure of domain-swapped STE20 OSR1 kinase domain.

Authors:  Seung-Jae Lee; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

8.  A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Authors:  Rachel M Sammons; Nicole A Perry; Yangmei Li; Eun Jeong Cho; Andrea Piserchio; Diana P Zamora-Olivares; Ranajeet Ghose; Tamer S Kaoud; Ginamarie Debevec; Chandra Bartholomeusz; Vsevolod V Gurevich; Tina M Iverson; Marc Giulianotti; Richard A Houghten; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

9.  The structure of the MAP2K MEK6 reveals an autoinhibitory dimer.

Authors:  Xiaoshan Min; Radha Akella; Haixia He; John M Humphreys; Susan E Tsutakawa; Seung-Jae Lee; John A Tainer; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

10.  Epitope-guided engineering of monobody binders for in vivo inhibition of Erk-2 signaling.

Authors:  Jasdeep K Mann; Jordan F Wood; Anne Fleur Stephan; Emmanuel S Tzanakakis; Denise M Ferkey; Sheldon Park
Journal:  ACS Chem Biol       Date:  2012-12-18       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.